Navigation Links
DURECT Corporation Invites You to Join its First Quarter 2013 Earnings Conference Call
Date:4/24/2013

CUPERTINO, Calif., April 24, 2013 /PRNewswire/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) first quarter 2013 financial results press release, you are invited to listen to the conference call that will be broadcast live over the internet on Thursday, May 2, 2013 at 4:30 pm Eastern Time (1:30 pm Pacific Time).

(Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO)

A live audio webcast of the presentation will be available by accessing DURECT's homepage at http://www.durect.com and clicking "Investor Relations."  If you are unable to participate during the live webcast, the call will be archived on DURECT's website under Audio Archive in the "Investor Relations" section.

About DURECT Corporation
DURECT is a specialty pharmaceutical company developing innovative drugs for pain and other chronic diseases, with late-stage development programs including REMOXY®, POSIDUR, ELADUR®, and TRANSDUR®-Sufentanil.  DURECT's proprietary oral, transdermal and injectable depot delivery technologies may enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs.  For more information, please visit www.durect.com.

NOTE: POSIDUR, SABER®, ORADUR®, TRANSDUR®, and ELADUR® are trademarks of DURECT Corporation. Other referenced trademarks belong to their respective owners.  REMOXY, POSIDUR, ELADUR and TRANSDUR-Sufentanil are drug candidates under development and have not been approved for commerc
'/>"/>

SOURCE DURECT Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology
2. DURECT Corporation Announces First Quarter 2012 Financial Results and Update of Programs
3. DURECT Corporation Announces Second Quarter 2012 Financial Results and Update of Programs
4. DURECT to Participate in Upcoming Healthcare Conferences
5. DURECT Corporation Invites You to Join its Third Quarter 2012 Earnings Conference Call
6. DURECT Corporation Announces Third Quarter 2012 Financial Results and Update of Programs
7. DURECT Corporation Invites You to Join its Fourth Quarter 2012 Earnings Conference Call
8. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
9. CVS Caremark Corporation to Hold First Quarter 2012 Conference Call
10. Richard Wolf Medical Instruments Corporation: 40 Years of Innovation
11. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... 4, 2015 According to a ... Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis) by Procedure (Therapeutic Apheresis, ... - Global Forecast to 2020", published by MarketsandMarkets, the ... Billion by 2020, growing at a CAGR of 11.2% ... Browse 139 Tables and 45 F ...
(Date:9/4/2015)... , Sept. 4, 2015  Cumberland Pharmaceuticals (CPIX), today ... present live at VirtualInvestorConferences.com on September 10, 2015. ... ET LINK: http://tinyurl.com/sep10pre ... investors are invited to ask the company questions in ... as the association,s "virtual trade booth." If attendees are ...
(Date:9/4/2015)... DUBLIN , Sept. 4, 2015  Allergan plc (NYSE: ... that Brent Saunders , CEO and President of Allergan, ... at the Morgan Stanley Global Healthcare Conference 2015 in ... http://photos.prnewswire.com/prnh/20150612/222796LOGO The presentation will take ... Time at the Grand Hyatt New York, 109 East 42nd ...
Breaking Medicine Technology:Apheresis Market Worth 2.5 Billion USD by 2020 2Apheresis Market Worth 2.5 Billion USD by 2020 3Apheresis Market Worth 2.5 Billion USD by 2020 4Apheresis Market Worth 2.5 Billion USD by 2020 5Cumberland Pharmaceuticals to Webcast, Live, at VirtualInvestorConferences.com September 10 2Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 2Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 3
... Lilly and Company announced today that Phase III trial ... for injection) to the current standard of care provided ... years for women with locally advanced cervical cancer. ... women,s cancer, and the second most common cause of ...
... and SOUTH SAN FRANCISCO, Calif. , May 30 ... carfilzomib solid tumor program in an oral presentation at ... Oncology (ASCO) in Orlando, Florida. Data from a ... trial of carfilzomib in relapsed patients with advanced solid ...
Cached Medicine Technology:Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 2Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 3Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 4Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 5Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 6Proteolix Presents Phase 1b/2 Clinical Data for Carfilzomib in Advanced Solid Tumor Patients at the 2009 ASCO Annual Meeting 2Proteolix Presents Phase 1b/2 Clinical Data for Carfilzomib in Advanced Solid Tumor Patients at the 2009 ASCO Annual Meeting 3Proteolix Presents Phase 1b/2 Clinical Data for Carfilzomib in Advanced Solid Tumor Patients at the 2009 ASCO Annual Meeting 4
(Date:9/4/2015)... , ... September 04, 2015 , ... The USC Eye ... ranked number 9 nationwide by Doximity. Faculty, residents and staff are honored to ... pride in the quality of our ophthalmology residency program. Our faculty places a high ...
(Date:9/4/2015)... ... 2015 , ... Having access to a doctor can sometimes be a challenge ... unnecessary emergency room visits which affects hospitals’ abilities to provide quality service to those ... solution to alleviate this problem has recently presented itself, the new telemedicine platform and ...
(Date:9/4/2015)... ... September 04, 2015 , ... Lalonde Gordon ran a 44.64 seconds scorcher in ... in the men’s 400 meters final, with an impressive 44.89 seconds at the 2015 ... Jose, Costa Rica in August 2015. The 44.64 time is a new NACAC Championship ...
(Date:9/4/2015)... ... September 04, 2015 , ... Compliance officers deal with ... the Stark physician self-referral law. “Stark Law DOs and DON’Ts: Best Practices ... Services, Inc. (AIS), will detail which deals are attracting the most government scrutiny ...
(Date:9/4/2015)... ... September 04, 2015 , ... FiltersFast.com, the online retail ... cannot be passed up. FiltersFast.com, will ship all orders over $50.00 for ... product replacements. Take advantage of this promotion now through September 8, 2015. , ...
Breaking Medicine News(10 mins):Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 3Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2Health News:FiltersFast.com Wows with a Long Labor Day Weekend Shipping Offer 2
... Vermont have uncovered the possible causes for brain disorders ... were// published November 1, 2006 in the prestigious journal ... for signaling regional blood flow changes in the brain. ... uninterrupted supply of oxygen and glucose, which is provided ...
... alcohol heavily over a short period of time or drink ... to face more depression than men, says a study.// ... Of Medicine and Health Sciences and other researchers studied the ... history of depression, according to the online edition of BBC ...
... Scientists have now uncovered graphic evidence that suggests a ... occurrence of herpes simplex infection//. The journal, Neurobiology of ... older individuals, the same gene is implicated in causing ... interest to the scientific world. It raises the possibility ...
... A compound derived from the bark of a tree could help ... new study.// ,The new molecule tazopsine was isolated ... science portal SciDev Net. ,Madagascar is an island ... It is the fourth largest island in the world and is ...
... before and for 24 hours after stent placement or ... any significant// treatment effect compared to placebo, according to ... had shown promise in preliminary studies. ,Acute ST-elevation ... following a heart attack) is a major public health ...
... issue of the Journal of the National Cancer Institute, the ... 2005 was $2.3// billion in the first year after diagnosis. ... of cancer care, but few have attempted to include a ... traveling to and from care, waiting for appointments, and receiving ...
Cached Medicine News:Health News:Potential Key to Brain Blood-Flow Disorders Explored by Scientists 2Health News:Potential Key to Brain Blood-Flow Disorders Explored by Scientists 3Health News:Potential Key to Brain Blood-Flow Disorders Explored by Scientists 4Health News:Herpes Simplex and Alzheimer’s Disease Linked to Single Gen 2Health News:Herpes Simplex and Alzheimer’s Disease Linked to Single Gen 3Health News:Herpes Simplex and Alzheimer’s Disease Linked to Single Gen 4Health News:Drug Therapy Offers Little Benefit for Some Patients Undergoing Angioplasty or Stent Procedure 2Health News:Cancer Care-Patient's Time Costs Studied 2
... the M3 and M4 monitors offer wireless ... care. M Series monitors are equipped with ... set of non-invasive parameters and input for ... extensions offer Mainstream or Microstream® CO 2 ...
Compact networked patient monitors for flexible care....
... on Philips strong heritage in patient monitoring, ... extensive clinical measurements menu; built-in clinical support ... 12-lead ECG, and arrhythmia analysis; and many ... to use and operates on a networked ...
... expands hospital-grade monitoring capabilities into the growing ... disease state management. The system is ... full range of clinical applications, from continuous ... to periodic monitoring of patients outside the ...
Medicine Products: